Pfizer nears deal to acquire Medivation for close to $14 billion

(Reuters) - Pfizer Incis in advanced talks to acquire U.S. cancer drug company Medivation Incfor close to $14 billion, as it seeks to boost its oncology portfolio, people familiar with the matter...